Severe atopic dermatitis: DS Biopharma announces positive top-line Phase IIa trial results for DS107

DS Biopharma (DS), a privately held biopharmaceutical company, has announced positive top-line results from a Phase IIa clinical trial of oral DS107 (active pharmaceutical ingredient DGLA) in...